GlassScriptPhysician profile
Alan J Murnane
NPI 1518945559
$6,128.26
in general payments reported to CMS, 2019-2025
33 companies · $1,022 in 2025
The $1,022 reported for 2025 was more than what 91% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $242 · 2020: $359 · 2021: $688 · 2022: $1,146 · 2023: $1,588 · 2024: $1,084 · 2025: $1,022.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,452 · Education: $242.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,451.67 |
| Education | $241.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,308.23 | 2019-2025 | |
| Astellas Pharma US INC | $757.92 | 2022-2025 | Veozah, Myrbetriq |
| Pfizer INC. | $548.23 | 2019-2025 | |
| Mayne Pharma Commercial LLC | $485.28 | 2021-2025 | Bijuva |
| Exact Sciences Corporation | $418.67 | 2023-2025 | Cologuard Collection Kit |
| Biogen, INC. | $315.45 | 2024-2025 | Zurzuvae |
| Sumitomo Pharma America, INC. | $228.06 | 2023-2025 | Myfembree |
| Biohaven Pharmaceutical Holding Company LTD. | $226.80 | 2022 | |
| Minerva Surgical, INC | $191.14 | 2019-2025 | |
| Corcept Therapeutics | $183.18 | 2023-2025 | Korlym |
| Therapeuticsmd, INC. | $162.95 | 2019-2022 | |
| Evofem Biosciences, INC. | $145.07 | 2021-2022 | |
| Hologic Sales and Service, LLC | $133.57 | 2019-2025 | Acessa Provu System, Myosure Tissue Removal Device, Novasure |
| Daiichi Sankyo INC. | $113.82 | 2024-2025 | Injectafer |
| Mylan Pharmaceuticals INC. | $90.01 | 2021-2022 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $88.17 | 2023-2025 | Slynd |
| Allergan, INC. | $75.77 | 2020-2021 | |
| Agile Therapeutics, INC. | $73.24 | 2022-2023 | Twirla |
| Bayer Healthcare Pharmaceuticals INC. | $73.03 | 2019-2022 | |
| Shield Therapeutics INC | $68.13 | 2022-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $66.93 | 2020-2024 | Xifaxan, Trulance |
| Biohaven Pharmaceuticals, INC. | $63.79 | 2021 | |
| Aspira Women'S Health INC | $50.08 | 2024 | Ova1 |
| Lupin INC. | $44.04 | 2019-2020 | |
| Millicent US INC | $42.91 | 2024-2025 | Intrarosa, Femlyv |
| Organon LLC | $41.77 | 2021-2024 | |
| Vertical Pharmaceuticals, LLC | $31.08 | 2019-2020 | |
| Alfasigma USA, INC. | $24.69 | 2020-2021 | |
| Kyowa Kirin, INC. | $18.40 | 2025 | |
| Medicem INC. | $15.86 | 2020 | |
| Avion Pharmaceuticals | $15.86 | 2022 | |
| Merck Sharp & Dohme LLC | $13.58 | 2021 | |
| Amag Pharmaceuticals, INC. | $12.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Murnane listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.